Altasciences Advances Nasal Irrigation Therapy into Clinical Investigation
1 report, 1 independent
Updated Thu 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Altasciences announced that its formulation work supporting 4B Healthcare Inc. has advanced the RhineX nasal irrigation rinse therapy into clinical investigation. This work involved R&D manufacturing, stability testing, and quality assurance support at Altasciences’ CDMO facility in Harleysville, PA. First subject dosing is planned for October 2026.
From intelligencer.ca
Why it matters
The successful partnership validates Altasciences' capabilities in drug product development and manufacturing for emerging pharmaceutical companies. The advancement into Phase I clinical trials is a significant milestone for RhineX and its developers.
From intelligencer.ca
Who's involved
- AltasciencesProvides CDMO services and manufacturing support for pharmaceutical clients.
- TennesseeThe state where the company receiving services is based.
Keep exploring
The entities involved
-
Altasciences
pharmaceutical company
Nothing else this week.
-
Tennessee
state of the United States of America